The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Validation of a Real-Time PCR–Based Qualitative Assay for the Detection of Methylated SEPT9 DNA in Human Plasma
Open accessAbstract
BACKGROUND: Epi proColon® is a new blood-based colorectal cancer (CRC) screening test designed to determine the methylation status of a promoter region of the SEPT9 (septin 9) gene in cell-free DNA isolated from plasma. We describe the analytical and clinical performance of the test. METHODS: Analytical performance at 4 testing laboratories included determination of limit of detection, precision, and reproducibility of the SEPT9 test. Clinical performance was evaluated in a prospective study by use of samples (n = 1544) from subjects enrolled in the PRESEPT clinical trial. Results were analyzed by comparison with colonoscopy, the reference standard. RESULTS: The limit of detection for methylated SEPT9 DNA was 7.8 pg/mL (95% CI 6–11 pg/mL) corresponding to <2 genome copies of methylated SEPT9 per milliliter of plasma. In the prospective clinical trial, sensitivity for all stages of CRC was 68% (95% CI 53%–80%) and for stage I–III CRC, 64% (48%–77%). Adjusted specificity, on the basis of negative colonoscopy findings, was 80.0% (78%–82%). SIGNIFICANCE: The Epi proColon test is a simple, real-time PCR–based assay for the detection of methylated SEPT9 DNA in blood that may provide a noninvasive CRC screening alternative for people noncompliant with current CRC screening guidelines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2025) · doi:10.32614/r.manuals · Cited by 352,181
Siegel, R., Naishadham, D., & Jemal, A. (2013) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21166 · Cited by 11,825
Reducing Mortality from Colorectal Cancer by Screening for Fecal Occult Blood
Mandel, J. S., Bond, J. H., Church, T. R., Snover, D. C., Bradley, G. M., Schuman, L. M., & Ederer, F. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305133281901 · Cited by 3,229
Levin, B., Lieberman, D. A., McFarland, B., Andrews, K. S., Brooks, D., Bond, J., Dash, C., Giardiello, F. M., Glick, S., Johnson, D., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.02.002 · Cited by 2,990
Cell-free nucleic acids as biomarkers in cancer patients
Schwarzenbach, H., Hoon, D. S. B., & Pantel, K. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3066 · Cited by 2,891
Screening for Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement
U.S. Preventive Services Task Force* (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-9-200811040-00243 · Cited by 1,959
Levin, B., Lieberman, D. A., McFarland, B., Smith, R. A., Brooks, D., Andrews, K. S., Dash, C., Giardiello, F. M., Glick, S., Levin, T. R., et al. (2008) · CA: A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0018 · Cited by 1,801
The Effect of Fecal Occult-Blood Screening on the Incidence of Colorectal Cancer
Mandel, J. S., Church, T. R., Bond, J. H., Ederer, F., Geisser, M. S., Mongin, S. J., Snover, D. C., & Schuman, L. M. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011303432203 · Cited by 1,423
Saslow, D., Solomon, D., Lawson, H. W., Killackey, M., Kulasingam, S. L., Cain, J., Garcia, F. A. R., Moriarty, A. T., Waxman, A. G., Wilbur, D. C., et al. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21139 · Cited by 1,390
Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps
Maisonneuve, P., Botteri, E., & Lowenfels, A. B. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.04.039 · Cited by 1,183
Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer
Church, T. R., Wandell, M., Lofton-Day, C., Mongin, S. J., Burger, M., Payne, S. R., Castaños-Vélez, E., Blumenstein, B. A., Rösch, T., Osborn, N., et al. (2014) · Gut · doi:10.1136/gutjnl-2012-304149 · Cited by 796
Self-citationAdherence to Colorectal Cancer Screening: A Randomized Clinical Trial of Competing Strategies
Vijan, S. (2012) · Archives of Internal Medicine · doi:10.1001/archinternmed.2012.332 · Cited by 552
MORIKAWA, T., KATO, J., YAMAJI, Y., WADA, R., MITSUSHIMA, T., & SHIRATORI, Y. (2005) · Gastroenterology · doi:10.1016/j.gastro.2005.05.056 · Cited by 539
Circulating Methylated SEPT9 DNA in Plasma Is a Biomarker for Colorectal Cancer
deVos, T., Tetzner, R., Model, F., Weiss, G., Schuster, M., Distler, J., Steiger, K. V., Grützmann, R., Pilarsky, C., Habermann, J. K., et al. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.115808 · Cited by 522
Self-citationDNA Methylation Biomarkers for Blood-Based Colorectal Cancer Screening
Lofton-Day, C., Model, F., DeVos, T., Tetzner, R., Distler, J., Schuster, M., Song, X., Lesche, R., Liebenberg, V., Ebert, M., et al. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2007.095992 · Cited by 493
Self-citationEhrich, M., Deciu, C., Zwiefelhofer, T., Tynan, J. A., Cagasan, L., Tim, R., Lu, V., McCullough, R., McCarthy, E., Nygren, A. O. H., et al. (2011) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2010.12.060 · Cited by 472
Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer
Warren, J. D., Xiong, W., Bunker, A. M., Vaughn, C. P., Furtado, L. V., Roberts, W. L., Fang, J. C., Samowitz, W. S., & Heichman, K. A. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-133 · Cited by 438
Sensitive Detection of Colorectal Cancer in Peripheral Blood by Septin 9 DNA Methylation Assay
Grützmann, R., Molnar, B., Pilarsky, C., Habermann, J. K., Schlag, P. M., Saeger, H. D., Miehlke, S., Stolz, T., Model, F., Roblick, U. J., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003759 · Cited by 394
Self-citationThe pathobiology of the septin gene family
Hall, P. A., & Russell, S. H. (2004) · The Journal of Pathology · doi:10.1002/path.1654 · Cited by 323
Whole Body Mechanics of Stealthy Walking in Cats
Bishop, K. L., Pai, A. K., & Schmitt, D. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003808 · Cited by 321
Next-Generation Stool DNA Test Accurately Detects Colorectal Cancer and Large Adenomas
Ahlquist, D. A., Zou, H., Domanico, M., Mahoney, D. W., Yab, T. C., Taylor, W. R., Butz, M. L., Thibodeau, S. N., Rabeneck, L., Paszat, L. F., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.10.031 · Cited by 315
Colorectal cancer screening—optimizing current strategies and new directions
Kuipers, E. J., Rösch, T., & Bretthauer, M. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.12 · Cited by 211
Tóth, K., Sipos, F., Kalmár, A., Patai, Á. V., Wichmann, B., Stoehr, R., Golcher, H., Schellerer, V., Tulassay, Z., & Molnár, B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046000 · Cited by 186
Joseph, D. A., King, J., Miller, J. W., & Richardson, L. C. (2012) · PubMed · Cited by 185
Characterization of circulating DNA in healthy human plasma
Suzuki, N., Kamataki, A., Yamaki, J., & Homma, Y. (2008) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.09.001 · Cited by 179
Oh, T., Kim, N., Moon, Y., Kim, M. S., Hoehn, B. D., Park, C. H., Kim, T. S., Kim, N. K., Chung, H. C., & An, S. (2013) · The Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2013.03.004 · Cited by 176
Johnson, D. A., Barclay, R. L., Mergener, K., Weiss, G., König, T., Beck, J., & Potter, N. T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098238 · Cited by 176
Self-citationMulti-Purpose Utility of Circulating Plasma DNA Testing in Patients with Advanced Cancers
Perkins, G., Yap, T. A., Pope, L., Mulick, A. R., Dukes, J. P., Riisnaes, R., Massard, C., Cassier, P. A., Miranda, S., Clark, J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047020 · Cited by 152
Aberrant septin 9 DNA methylation in colorectal cancer is restricted to a single CpG island
Wasserkort, R., Kalmár, A., Valcz, G., Spisák, S., Krispin, M., Tóth, K., Tulassay, Z., Sledziewski, A., & Molnar, B. A. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-398 · Cited by 143
Colonoscopy for Colorectal Cancer Screening
Young, P. E., & Womeldorph, C. M. (2013) · Journal of Cancer · doi:10.7150/jca.5829 · Cited by 134
Payne, S. R. (2010) · Epigenomics · doi:10.2217/epi.10.35 · Cited by 131
The Effect of Fecal Occult-Blood Screening on the Incidence of Colorectal Cancer.
&NA; (2001) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200101000-00021 · Cited by 124
Genome-Scale Discovery of DNA-Methylation Biomarkers for Blood-Based Detection of Colorectal Cancer
Lange, C. P. E., Campan, M., Hinoue, T., Schmitz, R. F., Jong, A. E. V. D. M., Slingerland, H., Kok, P. J. M. J., van Dijk, C. M., Weisenberger, D. J., Shen, H., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050266 · Cited by 120
Connolly, D., Abdesselam, I., Verdier‐Pinard, P., & Montagna, C. (2011) · Biological Chemistry · doi:10.1515/bc.2011.073 · Cited by 109
Ladabaum, U., Allen, J., Wandell, M., & Ramsey, S. (2013) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0204 · Cited by 93
Translational control of SEPT9 isoforms is perturbed in disease
McDade, S. S., Hall, P. A., & Russell, S. E. H. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm003 · Cited by 65
LaPointe, L. C., Pedersen, S. K., Dunne, R. A., Brown, G. S., Pimlott, L. K., Gaur, S., McEvoy, A., Thomas, M. L., Wattchow, D. A., Molloy, P. L., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029059 · Cited by 51
Ahmed, D., Danielsen, S. A., Ågesen, T. H., Bretthauer, M., Thiis‐Evensen, E., Hoff, G. S., Rognum, T. O., Nesbakken, A., Lothe, R. A., & Lind, G. E. (2012) · Clinical and Translational Gastroenterology · doi:10.1038/ctg.2012.21 · Cited by 35
Cited by
Wolf, A. M. D., Fontham, E. T. H., Church, T. R., Flowers, C. R., Guerra, C. E., LaMonte, S. J., Etzioni, R., McKenna, M. T., Oeffinger, K. C., Shih, Y. T., et al. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21457 · Cited by 1,944
Lin, J. S., Bowles, E. J. A., Williams, S. B., & Morrison, C. C. (2017) · JAMA · doi:10.1001/jama.2017.0562 · Cited by 1,082
Sensitive tumour detection and classification using plasma cell-free DNA methylomes
Shen, S. Y., Singhania, R., Fehringer, G., Chakravarthy, A., Roehrl, M. H. A., Chadwick, D., Zuzarte, P. C., Borgida, A., Wang, T. T., Li, T., et al. (2018) · Nature · doi:10.1038/s41586-018-0703-0 · Cited by 983
Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers
Okugawa, Y., Grady, W. M., & Goel, A. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.07.011 · Cited by 782
Strategies for Colorectal Cancer Screening
Ladabaum, U., Dominitz, J. A., Kahi, C., & Schoen, R. E. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.06.043 · Cited by 696
Metadata
- Authors
- Potter, N. T., Hurban, P., White, M. N., Whitlock, K. D., Lofton-Day, C. E., Tetzner, R., Koenig, T., Quigley, N. B., & Weiss, G.
- Venue
- Clinical Chemistry
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-09-01
- Volume
- 60
- Issue
- 9
- Pages
- 1183-1191
- ISSN
- 0009-9147 (ISSN-L)
- 1530-8561
- OpenAlex
- W2131201242
- Cited by
- 289
- References
- 38
- FWCI
- 8.04
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.